AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CAPTOPRIL 50 Mg ;

10 registrations across 1 African market— 10 active

Markets with CAPTOPRIL 50 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Capoten 50 mg
Tablets
🇪🇬EgyptSMITHKLINE BEECHAM-EGYPTactive
CAPOTRIL 50 mg
SCORED TABLET
🇪🇬EgyptEgyptian International Pharmaceutical Industries Company (EIPICO)active
Prilocapt 50 mg
Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Farcopril 50 mg
Tablets
🇪🇬Egyptislamic company for pharmaceuticals,chemicals and medical appliances (pharco pharmaceuticalsactive
Captodou 50mg
Oro-dispersible Film
🇪🇬EgyptNerhadou International for Pharmaceuticals and Neutraceuticalsactive
Prilocapt 50 mg
Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Capoten 50 mg
Tablets
🇪🇬EgyptSMITHKLINE BEECHAM-EGYPTactive
CAPOTRIL 50 mg
SCORED TABLET
🇪🇬EgyptEgyptian International Pharmaceutical Industries Company (EIPICO)active
Farcopril 50 mg
Tablets
🇪🇬Egyptislamic company for pharmaceuticals,chemicals and medical appliances (pharco pharmaceuticalsactive
Captodou 50mg
Oro-dispersible Film
🇪🇬EgyptNerhadou International for Pharmaceuticals and Neutraceuticalsactive

CAPTOPRIL 50 Mg ; in Africa — Regulatory Overview

CAPTOPRIL 50 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.